There are few listed companies that consistently deliver positive news to their holders. If anyone is more satisfied with the growth, financial position, executive team, product and long term sales contracts in place with any other company, I’d be quite surprised.
Amazing work team! Adding another ~$5m/year to revenue should see $20m+ this FY as well as decreased operational costs.
Wouldn’t be surprised to see the last few large parcels being offloaded by the recent seller/s before we see a true reflection of ECS value being priced in. Still a significant discount to true value.
GLTAH and DYOR.
Ann: $24 Million Supply Agreement with Medicann Health, page-3
Add ECS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.19M | |||
| Open | High | Low | Value | Volume |
| 1.8¢ | 1.8¢ | 1.8¢ | $5.086K | 282.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 2106000 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 3100000 | 2 |
View Market Depth
| Last trade - 15.35pm 10/07/2024 (20 minute delay) ? |
| ECS (ASX) Chart |